MedPath

The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation

Phase 1
Completed
Conditions
Human
Sperm
Cryopreservation
Myoinositol
Interventions
Biological: Myoinositol
Registration Number
NCT03153436
Lead Sponsor
Sohag University
Brief Summary

The objective of this study is to evaluate the effect of in-vitro myoinositol supplementation of human sperm on the outcome of cryopreservation.

Detailed Description

Sperm cryopreservation is considered the most valuable and used way to preserve male reproductive function. Unfortunately, osmotic effects of freezing and thawing during the cryopreservation process negatively affect sperm morphology and motility .

Myoinositol is the most biologically important form of inositol in nature. In male reproductive system, myoinositol appears to regulate sperm motility, capacitation and acrosomal reaction.

The objective of this study is to evaluate the effect of in-vitro myoinositol supplementation of human sperm on the outcome of cryopreservation.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
41
Inclusion Criteria
  • Infertile men with normal or abnormal semen analysis
Exclusion Criteria
  • Azoospermic samples

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Abnormal S.A groupMyoinositolInfertile men with abnormal semen analysis. each sample is divided into 2 identical aliquots: one aliquot (Myo aliquot) is supplied with myoinositol, The other aliquot is left as it is (control aliquot).
Normal S.A groupMyoinositolInfertile men with normal semen analysis. each sample is divided into 2 identical aliquots: one aliquot (Myo aliquot) is supplied with myoinositol, The other aliquot is left as it is (control aliquot).
Primary Outcome Measures
NameTimeMethod
Cryo-survival rate7 months

Post-thawing cryo-survival rates of both aliquots ( myo and control) are compared in both groups (A and B).

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath